GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (OTCPK:GALDY) » Definitions » Repurchase of Stock

GALDY (Galderma Group AG) Repurchase of Stock : $0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Repurchase of Stock?

Galderma Group AG's Repurchase of Stock for the six months ended in Dec. 2024 was $0 Mil.

Galderma Group AG's Repurchase of Stock for the trailing twelve months (TTM) ended in Dec. 2024 was $0 Mil.

Galderma Group AG Repurchase of Stock Historical Data

The historical data trend for Galderma Group AG's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Repurchase of Stock Chart

Galderma Group AG Annual Data
Trend Dec23 Dec24
Repurchase of Stock
- -15.00

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24
Repurchase of Stock - - - -

Galderma Group AG Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

Repurchase of Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG Repurchase of Stock Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Repurchase of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (OTCPK:GALDY) » Definitions » Repurchase of Stock
Comparable Companies
XSWX:SDZ XSWX:PPGN XSWX:SFZN XSWX:CURN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 TSE:4507 SZSE:000538 UTHR NSE:TORNTPHARM BOM:543904 BOM:500124
Traded in Other Exchanges
GDERF:USA GALDz:UK PY30:Germany GALD:Switzerland
Address
Zahlerweg 10, Zug, CHE, 6300
Website
https://www.galderma.com
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.